Corebridge Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62,602	Closed	-$1.04M	–	23
2025 Q1	$1.04M	Buy	62,602 +3,106	+5%	+$51.6K	0.01%	1241
2024 Q4	$1.09M	Sell	59,496 -4,491	-7%	-$82.4K	0.01%	1290
2024 Q3	$984K	Sell	63,987 -394	-0.6%	-$6.06K	0.01%	1367
2024 Q2	$1.05M	Buy	+64,381	New	+$1.05M	0.01%	1311